Board Meeting6 Aug 2026, 06:30 pm
Supriya Lifescience Board Meeting on Aug 13 to Approve Q1 FY27 Results
AI Summary
Supriya Lifescience Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results for the first quarter ended June 30, 2026. Concurrently, the company has closed its 'Trading Window' for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the declaration of these financial results, in line with its Insider Trading Prevention Code.
Key Highlights
- Board meeting scheduled for August 13, 2026.
- To approve Unaudited Financial Results for Q1 FY27.
- Trading window closed from July 1, 2026.
- Closure lasts until 48 hours post-results declaration.
Price Impact
More from SUPRIYA